Records containing: Prostate Cancer Metastatic Disease

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-04-23
Preclinical ex Vivo Patient-derived 3D Cultures for the Prediction of Prostate Cancer Treatment Response
CLINICAL_TRIALS study record update · 2026-03-25
Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP Patients
CLINICAL_TRIALS study record update · 2026-03-09
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy (Fezo-ADT Trial)
CLINICAL_TRIALS study record update · 2026-03-04
Novel FAP-targeted Approach to Imaging Patients With or High-risk for Metastatic Prostate Cancer
CLINICAL_TRIALS study record update · 2026-02-27
Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection (Zopocianine), a Prostate-Specific Membrane Antigen (PSMA)-Targeted Fluorescent Agent, for the Intraoperative Imaging of Prostate Cancer
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2026-02-17
Prospective Evaluation of PSMA PET Imaging in Surveillance Post-Focal Therapy for Prostate Cancer (PSMA-FT Surveillance Study)
CLINICAL_TRIALS study record update · 2026-01-12
o A Prospective, Randomized, Open-Label, Phase II Study Evaluating the Efficacy of Tadalafil for the Prevention of Docetaxel-Induced Peripheral Neuropathy in Patients With Metastatic Prostate Cancer
CLINICAL_TRIALS study record update · 2026-01-06
A Phase I Study to Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients With Prostate Cancer
CLINICAL_TRIALS study record update · 2025-12-26
Prospective Evaluation of Imaging Response Biomarkers During [177Lu]Lu-PSMA in Metastatic Castration-resistant Prostate Cancer
CLINICAL_TRIALS study record update · 2025-12-15
Contribution of Race to Nutritional Approach to Lower Cardiovascular Risk Factors in Men Undergoing Androgen Deprivation Therapy
CLINICAL_TRIALS study record update · 2025-12-08
HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases
CLINICAL_TRIALS study record update · 2025-10-16
Phase 1/2 Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
CLINICAL_TRIALS study record update · 2025-07-16
Efficacy and Tolerability of Low-Dose Versus Standard-Dose Enzalutamide in Advance Prostate Cancer: a Real-World Evidence Study
CLINICAL_TRIALS study record update · 2025-05-28
Radiotherapy or Radical Prostatectomy Combined With Intense Androgen Deprivation Therapy for Newly Diagnosed Metastatic Prostate Cancer: A Multi-center Randomized Controlled Phase II Trial
CLINICAL_TRIALS study record update · 2025-04-08
The Prognostic Value of Quantitative Parameters Derived From Dual Scanning of FDG and PSMA PET/CT for Tumor Progression in Patients With Metastatic Hormone-sensitive Prostate Cancer Receiving Novel Hormone Therapy
CLINICAL_TRIALS study record update · 2025-03-21
Osteosclerotic Changes on Computed Tomography Predict Disease Progression and Poor Survival in Prostate Cancer
CLINICAL_TRIALS study record update · 2024-12-18
A Phase II Study of HRS-2189 Combined HRS-5041 in Metastatic Prostate Cancer
CLINICAL_TRIALS study record update · 2017-03-15
A Phase I Study Evaluating the Efficacy and Safety of Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer